Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A proof-of-concept trial of ATP-128 in colorectal cancer

Trial Profile

A proof-of-concept trial of ATP-128 in colorectal cancer

Phase of Trial: Phase I

Latest Information Update: 20 Nov 2018

At a glance

  • Drugs ATP 128 (Primary)
  • Indications Colorectal cancer
  • Focus Adverse reactions; Proof of concept
  • Most Recent Events

    • 20 Nov 2018 New trial record
    • 12 Nov 2018 According to an Amal Therapeutics media release, this clinical trial is expected to start in summer 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top